Category Archives: CAM Cost Effectiveness

Cost-effectiveness of music therapy in palliative care

Reminiscence music reportedly reduces the symptoms of depression in patients with dementia. It’s also effective for agitation and disruptive behavior in patients with dementia, and makes it easier to provide care.

Now, researchers from the Kaiser Foundation Hospital in Santa Clara, California report that music therapy makes fiscal sense as well. Continue reading Cost-effectiveness of music therapy in palliative care

Behavioral training and biofeedback to treat temporomandibular dysfunction

Temporomandibular joint (TMJ) dysfunction involves face pain, clicking sounds, and limited movement of the jaw. About 33% of the population has it; fewer need treatment.

This study suggests that cognitive behavioral therapy plus biofeedback is cost-effective treatment.

Continue reading Behavioral training and biofeedback to treat temporomandibular dysfunction

Follow-up: Reported cost-savings with CAM-oriented primary care

In a previous entry it was reported that over 7 years, patients visiting chiropractors and other CAM-oriented primary care doctors had 60% fewer hospitalizations, 62% less outpatient surgery, and 85% lower pharmaceutical costs compared with total network HMO (health maintenance organization).

These findings are important, but there were some questions, which lead researcher, Dr. Richard Sarnat, graciously agreed to address. Continue reading Follow-up: Reported cost-savings with CAM-oriented primary care

The next big issue facing dietary supplements — You be the CEO

Dr. Mark Moyad (photo) is Director of Preventive and Alternative Medicine at the University of Michigan Medical Center in Ann Arbor. His thoughts about the FDA’s plan to establish good manufacturing regulations for dietary supplements are published in Urology Times.

He also looks to the next big issue that will confront the supplement industry.

Once you know the issues, you can play the role of the pharmaceutical executive and decide if your product “Best Prostate Health” should be withdrawn from the market. Continue reading The next big issue facing dietary supplements — You be the CEO